Provided by Tiger Trade Technology Pte. Ltd.

Senestech Inc.

1.80
-0.0500-2.70%
Pre-market: 1.69-0.1100-6.11%06:01 EST
Volume:48.25K
Turnover:88.61K
Market Cap:9.40M
PE:-0.49
High:1.87
Open:1.85
Low:1.78
Close:1.85
52wk High:6.24
52wk Low:1.30
Shares:5.22M
Float Shares:4.94M
Volume Ratio:0.80
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6464
EPS(LYR):-8.8599
ROE:-77.79%
ROA:-38.54%
PB:0.83
PE(LYR):-0.20

Loading ...

SenesTech Inc. to Directly Manage Amazon Sales of Evolve™ Products, Aiming to Increase Revenue, Enhance Margins, and Strengthen Direct-to-Consumer E-Commerce Strategy

Reuters
·
Yesterday

Glenbrook Capital Management Reports Acquisition of SenesTech Inc. Common Shares

Reuters
·
Feb 07

Glenbrook Capital Management Acquires Common Shares of SenesTech Inc

Reuters
·
Feb 04

SenesTech Inc. Files Initial Beneficial Ownership Statement for Glenbrook Capital Management

Reuters
·
Feb 03

Senestech's Evolve® Approved in New Zealand

THOMSON REUTERS
·
Feb 02

SenesTech Evolve Approved for Use in New Zealand

Reuters
·
Feb 02

SenesTech Amends 8-K Filing to Add Missing Signature

Reuters
·
Jan 29

BRIEF-Senestech Inc - Joel L. Fruendt, President & CEO Of Co To Retire

Reuters
·
Jan 29

BRIEF-Senestech Announces CEO Transition Plan

Reuters
·
Jan 29

Senestech Inc - Jamie Bechtel Appointed Interim Executive Chair

THOMSON REUTERS
·
Jan 29

Senestech Inc - CEO Joel Fruendt Announces Intent to Retire

THOMSON REUTERS
·
Jan 29

Senestech Inc - on January 26, 2026 Jamie Bechtel Appointed Interim Executive Chair of Co - SEC Filing

THOMSON REUTERS
·
Jan 29

Senestech Inc - Joel L. Fruendt, President & CEO of Co to Retire - SEC Filing

THOMSON REUTERS
·
Jan 29

Senestech Inc - Retirement Effective by June 30, 2026 or Upon Successor Appointment - SEC Filing

THOMSON REUTERS
·
Jan 29

SenesTech Names Jamie Bechtel Interim Executive Chair as CEO Joel Fruendt Announces Retirement

Reuters
·
Jan 29

Polyrizon Stock Skyrockets After New Data Shows Naloxone Gel Outperforms Marketed Spray

Benzinga_recent_news
·
Dec 05, 2025

Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product

GlobeNewswire
·
Dec 03, 2025

SenesTech Director Jacob Steven Leach Reports Sale of Common Shares

Reuters
·
Nov 20, 2025

SenesTech Q3 Revenue USD 690 Thousand

Reuters
·
Nov 20, 2025

SenesTech Director Matthew K. Szot Reports Sale of Common Shares

Reuters
·
Nov 18, 2025